The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells.

Many anticancer drugs arrest cells in G2 of the cell cycle and subsequently induce cell death by apoptosis. The current experiments establish a detailed sequence of events that occur in Chinese hamster ovary CHO/UV41 cells following incubation with cisplatin. Synchronized CHO/UV41 cells were damaged with cisplatin in early S. The cells progressed at a normal rate through S but arrested in G2. The arrested cells exhibited normal levels of the mitosis-promoting kinase p34cdc2 in its fully phosphorylated, inactive form. After a protracted arrest, the cells dephosphorylated p34cdc2 and underwent an aberrant mitosis and cytokinesis in which the chromosomes segregated unequally due to the formation of multipolar mitotic spindles. These cells subsequently lost contact with the extracellular matrix, and only then digested their DNA in a manner characteristic of apoptosis. This sequence of events could be dramatically accelerated by the addition of caffeine to G2-arrested cells, which induced dephosphorylation of p34cdc2 and passage through an aberrant mitosis. It has previously been suggested that protein synthesis is required for both caffeine-induced premature mitosis and apoptosis. However, when added in G2, cycloheximide could inhibit neither the caffeine-induced mitosis nor apoptosis. Inhibition was only seen if cycloheximide was added during S before complete synthesis of the proteins required for mitosis. These results demonstrate that, in this model, the proteins thought to be involved in apoptosis are those required for normal cell cycle progression. It is hypothesized that the DNA digestion results from loss of signal transduction originating from the extracellular matrix but that earlier events leading to loss of cell adhesion are critical for the induction of apoptosis.

[1]  J. Labbé,et al.  Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. , 1992, The EMBO journal.

[2]  A. Eastman,et al.  Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. , 1992, Biochemical and biophysical research communications.

[3]  Andrew W. Murray,et al.  The role of cyclin synthesis and degradation in the control of maturation promoting factor activity , 1989, Nature.

[4]  A. Pardee,et al.  Abolition by cycloheximide of caffeine-enhanced lethality of alkylating agents in hamster cells. , 1982, Cancer research.

[5]  A. Eastman Apoptosis: a product of programmed and unprogrammed cell death. , 1993, Toxicology and applied pharmacology.

[6]  Jean,et al.  Cyclin B targets p34cdc2 for tyrosine phosphorylation. , 1991, The EMBO journal.

[7]  D. Morrison,et al.  Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate , 1988, Nature.

[8]  C. Sorenson,et al.  Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. , 1988, Cancer research.

[9]  E. Rozengurt,et al.  Focal adhesion kinase (p125FAK): A point of convergence in the action of neuropeptides, integrins, and oncogenes , 1992, Cell.

[10]  A. Eastman,et al.  Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. , 1990, Biochemical pharmacology.

[11]  A. Eastman The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. , 1987, Pharmacology & therapeutics.

[12]  Z. Darżynkiewicz,et al.  Different rates of degradation of the proliferation-associated nuclear and nucleolar antigens during apoptosis of hl-60 cells induced by DNA topoisomerase inhibitors. , 1993, International journal of oncology.

[13]  R. Lock,et al.  Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. , 1992, Cancer research.

[14]  A. Eastman,et al.  Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. , 1993, Cancer research.

[15]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[16]  K. Kohn,et al.  G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. , 1993, The Journal of biological chemistry.

[17]  A. Eastman,et al.  The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? , 1992, Cancer investigation.

[18]  Kathleen L. Gould,et al.  Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis , 1989, Nature.

[19]  A. Kumagai,et al.  The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system , 1991, Cell.

[20]  D. Beach,et al.  Reversible tyrosine phosphorylation of cdc2: Dephosphorylation accompanies activation during entry into mitosis , 1989, Cell.

[21]  K. Kohn,et al.  Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  A. Eastman,et al.  Activation of a Genetic Program for Cell Death , 1991 .

[23]  A. Eastman,et al.  Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. , 1993, Archives of biochemistry and biophysics.

[24]  C. Sorenson,et al.  Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. , 1988, Cancer research.

[25]  Tony Hunter,et al.  Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 , 1989, Cell.

[26]  A. Pardee,et al.  Mechanism by which caffeine potentiates lethality of nitrogen mustard. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Lechene,et al.  Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Virginia A. Zakian,et al.  Loss of a yeast telomere: Arrest, recovery, and chromosome loss , 1993, Cell.

[29]  C. Sorenson,et al.  Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. , 1990, Journal of the National Cancer Institute.

[30]  R. Schiestl,et al.  Cloning and sequence analysis of the Saccharomyces cerevisiae RAD9 gene and further evidence that its product is required for cell cycle arrest induced by DNA damage , 1989, Molecular and cellular biology.

[31]  A. Zetterberg,et al.  Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. , 1990, Cancer research.

[32]  Marc W. Kirschner,et al.  cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2 , 1991, Cell.

[33]  D. Beach,et al.  Oscillation of MPF is accompanied by periodic association between cdc25 and cdc2-cyclin B , 1992, Cell.

[34]  L. Hartwell,et al.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. , 1988, Science.

[35]  G. Belinsky,et al.  Chemically induced premature mitosis: differential response in rodent and human cells and the relationship to cyclin B synthesis and p34cdc2/cyclin B complex formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Nurse Universal control mechanism regulating onset of M-phase , 1990, Nature.

[37]  L. Liu,et al.  The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B. , 1992, Cancer research.

[38]  D. Beach,et al.  Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components. , 1990, Genes & development.

[39]  A. Thomson,et al.  The mechanism of action of antitumor platinum compounds. , 1979, Progress in nucleic acid research and molecular biology.